Well there isn't any definite answer for what are you asking.
It's a combination of factors and a feeling, plus a lot of luck, and guess.
Times are much better given the AI potential availability recently for may industries. I think biotech biopharma will benefit from it greatly, I think.
Sometimes the Insiders activity may hint a clue. One never knows for sure. Better luck to you.
Market Data 
Markets 
AI
